TXL
Brand names,
TXL
Analogs
TXL
Brand Names Mixture
TXL
Chemical_Formula
C43H53NO14
TXL
RX_link
http://www.rxlist.com/cgi/generic3/docetaxel.htm
TXL
fda sheet
TXL
msds (material safety sheet)
TXL
Synthesis Reference
No information avaliable
TXL
Molecular Weight
807.879 g/mol
TXL
Melting Point
232 oC
TXL
H2O Solubility
Practically insoluble (0.025 mg/L)
TXL
State
Solid
TXL
LogP
4.258
TXL
Dosage Forms
Solution: single-dose vials containing 20 mg (0.5 mL) or 80 mg (2 mL) docetaxel (anhydrous).
TXL
Indication
For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer.
TXL
Pharmacology
Docetaxel is a taxoid antineoplastic agent. It promotes the assembly of microtubules from tubulin dimers and stabilizes microtubules by preventing depolymerization. This stability results in the inhibition of the normal dynamic reorganization of the microtubule network that is essential for vital interphase and mitotic cellular functions. In addition, docetaxel induces abnormal arrays or "bundles" of microtubules throughout the cell cycle and multiple asters of microtubules during mitosis.
TXL
Absorption
No information avaliable
TXL
side effects and Toxicity
Oral LD50 in rat is >2000 mg/kg. Anticipated complications of overdosage include: bone marrow suppression, peripheral neurotoxicity, and mucositis. In two reports of overdose, one patient received 150 mg/m2 and the other received 200 mg/m2 as 1-hour infusions. Both patients experienced severe neutropenia, mild asthenia, cutaneous reactions, and mild paresthesia, and recovered without incident.
TXL
Patient Information
TXL
Organisms Affected
Humans and other mammals